Vera Therapeutics VERA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $86.01M+108% | $59.31M+77.9% | $56.47M+40.1% | $58.2M+98.5% | $41.28M+77.9% | ||
| $39.12M+146% | $34.9M+124% | $27.46M+189% | $21.95M+173% | $15.92M+101% | ||
| $125.13M+119% | $94.21M+92.6% | $83.93M+68.5% | $80.14M+115% | $57.19M+83.8% | ||
| $125.13M+119% | $94.21M+92.6% | $83.93M+68.5% | $80.14M+115% | $57.19M+83.8% | ||
| -$125.13M-119% | -$94.21M-92.6% | -$83.93M-68.5% | -$80.14M-115% | -$57.19M-83.8% | ||
| $1.82M+1.7% | $1.9M+1.8% | $1.96M+1.2% | $1.87M-2.0% | $1.79M-6.0% | ||
| $6.36M-8.0% | $5.52M-17.2% | $5.74M+20.5% | $6.32M+23.8% | $6.91M+65.0% | ||
| $4.1M-25.5% | $3.11M-43.4% | $3.64M+14.8% | $3.61M-0.7% | $5.5M+102% | ||
| —— | -$74.9M-96.9% | -$74.9M-96.9% | -$74.9M-96.9% | -$74.9M-96.9% | ||
| -$121.03M-134% | -$91.1M-110% | -$80.29M-72.2% | -$76.53M-127% | -$51.69M-82.1% | ||
| -$1.69-109% | -$1.39-93.1% | -$1.26-48.2% | -$1.20-93.5% | -$0.81-44.6% | ||
| -$1.69-109% | -$1.39-93.1% | -$1.26-48.2% | -$1.20-93.5% | -$0.81-44.6% | ||
| 71.5M+12.3% | 64.2M+16.1% | 63.8M+16.3% | 63.8M+16.6% | 63.7M+24.9% | ||
| 71.5M+12.3% | 64.2M+16.1% | 63.8M+16.3% | 63.8M+16.6% | 63.7M+24.9% | ||
| -$942K-461% | —— | $354K-76.3% | -$127K+54.2% | $261K+162% | ||
| -$432K-212% | -$503K-172% | -$137K-140% | -$836K-289% | $386K-14.0% | ||
| -$125.13M-119% | -$94.21M-92.6% | -$83.93M-68.5% | -$80.14M-115% | -$57.19M-83.8% | ||
| -$124.99M-119% | -$94.07M-92.5% | -$83.8M-68.4% | -$80.02M-114% | -$57.11M-83.6% | ||
| -$124.99M-119% | -$94.07M-92.5% | -$83.8M-68.4% | -$80.02M-114% | -$57.11M-83.6% | ||
| -$125.13M-119% | -$94.21M-92.6% | -$83.93M-68.5% | -$80.14M-115% | -$57.19M-83.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Vera Therapeutics profitable?
- Vera Therapeutics is not currently profitable: it reported a net loss of $369.0M over the trailing twelve months.
- What is Vera Therapeutics's earnings per share?
- Vera Therapeutics's diluted EPS over the trailing twelve months is $-5.54.
- Where does Vera Therapeutics's income statement data come from?
- Every line is extracted from Vera Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.